Erschienen in:
01.02.2006 | Letter
Do fluoroquinolones actually increase mortality in community-acquired pneumonia?
verfasst von:
Ritesh Agarwal
Erschienen in:
Critical Care
|
Ausgabe 1/2006
Einloggen, um Zugang zu erhalten
Excerpt
I read with interest the report by Mortensen and coworkers [
1], who found the use of initial empiric antimicrobial therapy with a β-lactam and a fluoroquinolone to be associated with increased short-term mortality in patients with severe community-acquired pneumonia (CAP) compared with other guideline-concordant antimicrobial regimens. However, the study has a number of limitations other than those stated by the authors. …